PRINTER'S NO. 564
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE RESOLUTION
No.
52
Session of
2017
INTRODUCED BY SCHWANK, SABATINA, FONTANA, DINNIMAN, GREENLEAF,
BROWNE, EICHELBERGER, RESCHENTHALER, BREWSTER, RAFFERTY,
COSTA, TARTAGLIONE, KILLION, VULAKOVICH, MENSCH, AUMENT AND
SCAVELLO, MARCH 22, 2017
INTRODUCED AND ADOPTED, MARCH 22, 2017
A RESOLUTION
Designating the month of March 2017 as "Fibromuscular Dysplasia
Awareness Month" in Pennsylvania.
WHEREAS, Fibromuscular dysplasia (FMD) is a disease that
causes abnormal cell growth of the arterial walls in the body
and can lead to areas of narrowing, beading, aneurysms and
tearing of areas of the arterial wall; and
WHEREAS, FMD is usually detected by accident or as a result
of a serious incident because its symptoms, including
hypertension, headaches and dizziness, affect much of the
general population; and
WHEREAS, There has been little progress in understanding the
disease since it was first diagnosed in 1938; and
WHEREAS, There is no known cause or cure for the disease, and
there are no set protocols for treatment; and
WHEREAS, FMD is classified as a rare disease, though many
researchers believe it is underdiagnosed; and
WHEREAS, Women between 20 and 60 years of age comprise 90% of
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
patients diagnosed with FMD; and
WHEREAS, Individuals and families affected by FMD often
experience isolation, difficulty in obtaining an accurate and
timely diagnosis and less than optimal treatment options, and
often patients must educate their own physicians about the
disease; and
WHEREAS, The Fibromuscular Dysplasia Society of America
(FMDSA) was founded in March 2003 and over the past 14 years has
been active and successful in raising public and medical
professional awareness of the disease, increasing patient
support and working with researchers around the world; and
WHEREAS, FMDSA is also funding the United States Registry for
Fibromuscular Dysplasia; and
WHEREAS, FMDSA is organizing a global observance of FMD to
have patients, medical professionals and researchers join
together to focus attention on FMD as a public health issue;
therefore be it
RESOLVED, That the Senate designate the month of March 2017
as "Fibromuscular Dysplasia Awareness Month" in Pennsylvania.
20170SR0052PN0564 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19